Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
by Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ.
Affliation: Epilepsy Unit, Section of Clinical Pharmacology & Stroke Medicine, University Division of Cardiovascular & Medical Sciences, Western Infirmary, Glasgow, Scotland. g.j.sills@clinmed.gla.ac.uk
Journal: Epilepsia. 46(5):643-7
Publication Date: Thursday, April 28, 2005
PubMed citation
|
[Pharmacogenetics in future medical care - implications for patients and physicians.]
by Rogausch A, Brockmöller J, Himmel W.
Affliation: Bereich Humanmedizin, Abteilung Allgemeinmedizin, Georg-August-Universität Göttingen. arogaus@gwdg.de.
Journal: Gesundheitswesen. 67(4):257-63
Publication Date: Wednesday, April 27, 2005
PubMed citation
|
The future of treatment research in anorexia nervosa.
by Strober M.
Affliation: Eating Disorders Program, Department of Psychiatry and Biobehavioral Sciences and Neuropsychiatric Institute and Hospital, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Journal: Int J Eat Disord. 37(S1):S90-S94
Publication Date: Tuesday, April 26, 2005
PubMed citation
|
Pharmacogenomics Education: International Society of Pharmacogenomics Recommendations for Medical, Pharmaceutical, and Health Schools Deans of Education.
by Gurwitz D, Lunshof JE, Dedoussis G, Flordellis CS, Fuhr U, Kirchheiner J, Licinio J, Llerena A, Manolopoulos VG, Sheffield LJ, Siest G, Torricelli F, Vasiliou V, Wong S.
Affliation: 1Department of Human Genetics & Molecular Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Journal: Pharmacogenomics J. :
Publication Date: Tuesday, April 26, 2005
PubMed citation
|
The third annual meeting of the International Society of Pharmacogenomics (ISP): a joint meeting with the International Union of Nutritional Sciences (IUNS) task force on genetics and nutrition.
by Sheffield LJ.
Affliation: [1] 1Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia [2] 2Department of Paediatrics, University of Melbourne, Melbourne, Australia.
Journal: Pharmacogenomics J. :
Publication Date: Tuesday, April 26, 2005
PubMed citation
|
Distinct proteomic profiles of amphetamine self-administration transitional states.
by Freeman WM, Brebner K, Amara SG, Reed MS, Pohl J, Phillips AG.
Affliation: 1Department of Pharmacology, Penn State College of Medicine, Hershey, PA, USA.
Journal: Pharmacogenomics J. :
Publication Date: Tuesday, April 26, 2005
PubMed citation
|
Adjuvant therapy for colon cancer.
by Sun W, Haller DG.
Affliation: Abramson Cancer Center, University of Pennsylvania, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA. weijing.sun@uphs.upenn.edu.
Journal: Curr Oncol Rep. 7(3):181-5
Publication Date: Monday, April 25, 2005
PubMed citation
|
Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
by Kweekel DM, Gelderblom H, Guchelaar HJ.
Affliation: Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
Journal: Cancer Treat Rev. 31(2):90-105
Publication Date: Monday, April 25, 2005
PubMed citation
|
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
by Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF.
Affliation: Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Journal: Thromb Haemost. 93(4):700-5
Publication Date: Wednesday, April 20, 2005
PubMed citation
|
Polymorphism at position -308 of the tumour necrosis factor {alpha} gene and rheumatoid arthritis pharmacogenetics.
by Fonseca JE, Carvalho T, Cruz M, Nero P, Sobral M, Mourão AF, Cavaleiro J, Ligeiro D, Abreu I, Carmo-Fonseca M, Branco JC.
Affliation: Rheumatoid Arthritis Unit, Institute of Molecular Medicine, University of Lisbon, Faculdade de Medicina, Avenue Professor Egas Moniz, 1649-028 Lisbon, Portugal. jefonseca@netcabo.pt.
Journal: Ann Rheum Dis. 64(5):793-4
Publication Date: Monday, April 18, 2005
PubMed citation
|
What Does the Future Hold for Irritable Bowel Syndrome and the Functional Gastrointestinal Disorders?
by Drossman DA.
Affliation: From the Department of Medicine and Psychiatry and UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Journal: J Clin Gastroenterol. 2005 May/June;39(5):S251-S256
Publication Date: Friday, April 15, 2005
PubMed citation
|
Warfarin: a case history in pharmacogenetics.
by Hall AM, Wilkins MR.
Affliation:
Journal: Heart. 91(5):563-4
Publication Date: Friday, April 15, 2005
PubMed citation
|
Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.
by Dervieux T, Meshkin B, Neri B.
Affliation: Prometheus Laboratories, 5739 Pacific Center Boulevard, San Diego, 92121 CA, USA. tdervieux@prometheuslabs.com
Journal: Mutat Res. 573(1-2):180-94
Publication Date: Thursday, April 14, 2005
PubMed citation
|
Pharmacogenomics and its applications.
by White RM, Wong SH.
Affliation: DSI Laboratories in Fort Myers, FL, USA.
Journal: MLO Med Lab Obs. 37(3):20-7
Publication Date: Thursday, April 14, 2005
PubMed citation
|
Assessment of two flexible and compatible SNP genotyping platforms: TaqMan((R)) SNP Genotyping Assays and the SNPlextrade mark Genotyping System.
by Vega FM, Lazaruk KD, Rhodes MD, Wenz MH.
Affliation: Applied Biosystems, 850 Lincoln Centre Dr., Foster City, CA 94404, USA.
Journal: Mutat Res. 573(1-2):111-35
Publication Date: Thursday, April 14, 2005
PubMed citation
|
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy.
by Russo A, Corsale S, Cammareri P, Agnese V, Cascio S, Di Fede G, Macaluso M, Bazan V.
Affliation: Department of Oncology, University of Palermo, Palermo, Italy.
Journal: J Cell Physiol. :
Publication Date: Wednesday, April 13, 2005
PubMed citation
|
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose.
by Herman D, Locatelli I, Grabnar I, Peternel P, Stegnar M, Mrhar A, Breskvar K, Dolzan V.
Affliation: 1Institute of Biochemistry, Faculty of Medicine, Ljubljana, Slovenia.
Journal: Pharmacogenomics J. :
Publication Date: Tuesday, April 12, 2005
PubMed citation
|
Genetics of platelet glycoprotein receptors: risk of thrombotic events and pharmacogenetic implications.
by Mikkelsson J, Perola M, Karhunen PJ.
Affliation: Tampere University Hospital, Research Unit and Medical School, University of Tampere, Tampere University Hospital, and National Public Health Institute, Helsinki, Finland. jussi.mikkelsson@dnainternet.net
Journal: Clin Appl Thromb Hemost. 11(2):113-25
Publication Date: Monday, April 11, 2005
PubMed citation
|
Tailoring drug therapy with pharmacogenetics.
by Lea DH.
Affliation:
Journal: Nursing. 35(4):22-3
Publication Date: Friday, April 08, 2005
PubMed citation
|
Pharmacogenetics of response to statins: where do we stand?
by Maitland-van der Zee AH, Boerwinkle E.
Affliation: Human Genetics Center, Health Science Center at Houston, -University of Texas, 1200 Hermann Pressler, Houston, TX 77030, USA. Eric.Boerwinkle@uth.tmc.edu.
Journal: Curr Atheroscler Rep. 7(3):204-8
Publication Date: Wednesday, April 06, 2005
PubMed citation
|
|
|
|